Warner Pharmaceutical: Net profit in Q3 2026 was 18.1939 million yuan, down 86.62% year on year.

Warner Pharmaceutical announced that in the third quarter of 2026, operating revenue was 306 million yuan, down 17.80% year on year; net profit attributable to shareholders of the listed company was 18.1939 million yuan, down 86.62% year on year; net profit after deducting non-recurring gains and losses was 20.6298 million yuan, down 48.02% year on year. In the first three quarters of 2026, operating revenue was 967 million yuan, down 10.98% year on year; net profit attributable to shareholders of the listed company was 82.7937 million yuan, down 60.03% year on year; net profit after deducting non-recurring gains and losses was 79.3508 million yuan, down 19.72% year on year.